Application 020745

Type
NDA
Sponsor
SANOFI US

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZANTAC 75RANITIDINE HYDROCHLORIDETABLET, EFFERVESCENT;ORALEQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
41639ORIG2005-05-18